Square Pharmaceuticals PLC. (DSE: SQURPHARMA)
Bangladesh
· Delayed Price · Currency is BDT
217.10
+0.70 (0.32%)
At close: Jan 28, 2025
DSE: SQURPHARMA Revenue
Square Pharmaceuticals PLC. had revenue of 17.75B BDT in the quarter ending September 30, 2024, a decrease of -0.36%. This brings the company's revenue in the last twelve months to 70.04B, up 8.60% year-over-year. In the fiscal year ending June 30, 2024, Square Pharmaceuticals PLC. had annual revenue of 70.10B with 15.47% growth.
Revenue (ttm)
70.04B
Revenue Growth
+8.60%
P/S Ratio
2.75
Revenue / Employee
5.62M
Employees
12,453
Market Cap
192.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 70.10B | 9.39B | 15.47% |
Jun 30, 2023 | 60.71B | 3.11B | 5.40% |
Jun 30, 2022 | 57.60B | 6.89B | 13.60% |
Jun 30, 2021 | 50.70B | 4.83B | 10.52% |
Jun 30, 2020 | 45.88B | 1.84B | 4.19% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grameenphone | 161.36B |
British American Tobacco Bangladesh Company | 93.12B |
Walton Hi-Tech Industries | 75.24B |
Robi Axiata PLC. | 101.06B |
Bangladesh Export Import Company | 25.18B |
BRAC Bank PLC. | 54.86B |
Berger Paints Bangladesh | 27.70B |
Marico Bangladesh | 15.21B |